Oscar Health (NYSE:OSCR) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen cut shares of Oscar Health (NYSE:OSCR) from a buy rating to a hold rating in a report issued on Sunday.

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Oscar Health has a consensus rating of “Hold” and an average price target of $16.50.

Oscar Health Trading Down 0.6%

OSCR opened at $14.67 on Friday. The company’s 50 day moving average is $13.93 and its 200-day moving average is $14.52. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market cap of $3.73 billion, a P/E ratio of -732.88 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same period last year, the company posted $0.62 EPS. The firm’s quarterly revenue was up 42.2% compared to the same quarter last year. Equities research analysts predict that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 24.39% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in OSCR. JPMorgan Chase & Co. raised its holdings in Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock worth $139,246,000 after purchasing an additional 8,051,379 shares during the last quarter. BIT Capital GmbH increased its stake in shares of Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C increased its stake in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after acquiring an additional 3,983,325 shares in the last quarter. Nuveen LLC bought a new stake in shares of Oscar Health in the 1st quarter valued at $29,684,000. Finally, Gilder Gagnon Howe & Co. LLC increased its stake in shares of Oscar Health by 51.4% in the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock valued at $85,154,000 after acquiring an additional 2,151,256 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.